PRA Health Sciences Inc

+0.61 (+0.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)6.17B
Current PE25.77
Forward PE 22.79
2yr Forward PE 17.38
See more stats
Estimates Current Quarter
Revenue$716.08 Million
Adjusted EPS$0.76
See more estimates
10-Day MA$94.42
50-Day MA$85.02
200-Day MA$97.93
See more pivots

PRA Health Sciences, Inc. Stock, NASDAQ:PRAH

United States of America
Phone: 9197868200
Number of Employees: 16400


PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It also provides product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company's services also comprise strategic solutions comprising embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services consisting of Phase I through Phase IIa studies and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, including oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina.